Litcius/Paper detail

Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial

Anant Mohan, Pawan Tiwari, Tejas Menon Suri, Saurabh Mittal, Ankit Patel, Avinash Jain, Thirumurthy Velpandian, Ujjalkumar Subhash Das, Tarun Krishna Boppana, Ravindra Mohan Pandey, Sushil Suresh Shelke, Angel Rajan Singh, Sushma Bhatnagar, Shet Masih, Shelly Mahajan, Tanima Dwivedi, Biswajeet Sahoo, Anuja Pandit, Shweta Bhopale, Saurabh Vig, Ritu Gupta, Karan Madan, Vijay Hadda, Nishkarsh Gupta, Rakesh Garg, Ved Prakash Meena, Randeep Guleria

2021Journal of Infection and Chemotherapy59 citationsDOIOpen Access PDF

Topics & Concepts

MedicineIvermectinPlaceboAdverse effectRandomized controlled trialPopulationInternal medicineAnesthesiaVeterinary medicinePathologyAlternative medicineEnvironmental healthParasitic Diseases Research and TreatmentParasites and Host InteractionsDermatological diseases and infestations